Title:
CLOTTING FACTOR VARIANTS AND THEIR USE
Document Type and Number:
WIPO Patent Application WO/2022/094493
Kind Code:
A3
Abstract:
Disclosed herein are novel variants of clotting factor IX and their use, for example, in methods of treating a subject with a clotting disorder, such as hemophilia A or hemophilia B.
Inventors:
D C DENNING GABRIELA (US)
DOERING CHRISTOPHER B (GE)
BROWN HARRISON (US)
DOERING CHRISTOPHER B (GE)
BROWN HARRISON (US)
Application Number:
PCT/US2021/065588
Publication Date:
June 30, 2022
Filing Date:
December 29, 2021
Export Citation:
Assignee:
D C DENNING GABRIELA (US)
DOERING CHRISTOPHER B (US)
BROWN HARRISON (US)
EXPRESSION THERAPEUTICS LLC (US)
UNIV EMORY (US)
CHILDREN’S HEALTHCARE OF ATLANTA (US)
DOERING CHRISTOPHER B (US)
BROWN HARRISON (US)
EXPRESSION THERAPEUTICS LLC (US)
UNIV EMORY (US)
CHILDREN’S HEALTHCARE OF ATLANTA (US)
International Classes:
A61K31/7088; A61K35/76; A61K38/00; A61K38/36
Domestic Patent References:
| WO2018208973A1 | 2018-11-15 |
Foreign References:
| US20080102115A1 | 2008-05-01 | |||
| US20210052740A1 | 2021-02-25 |
Attorney, Agent or Firm:
SCHAFER, Heather (US)
Download PDF:
Previous Patent: SYSTEM AND METHOD FOR ARRANGEMENTS OF VISUAL INFORMATION IN USER-CONFIGURABLE FORMAT
Next Patent: STRETCHING MACHINE
Next Patent: STRETCHING MACHINE